Hims & Hers Eyes Global Growth: Will $1.15B Eucalyptus Deal Fuel Its Recovery or Dilute Shareholders?

Summary

As the market finds itself in the thick of Q2 earnings season, there is—per usual—a considerable amount of noise. Companies that have handily beaten consensus expectations have been punished, while others have seen their shares surge despite dramatically missing analyst forecasts. But as unpredictable as the market’s reaction to some earnings can be, others have been painfully predictable. That has been especially true for telehealth platform Hims & Hers Health NYSE: HIMS.Get Hims & Hers Health alerts:Sign Up Following an enormous earnings miss and slightly less painful revenue miss earlier this month, shares of HIMS have sold off. The stock has found itself down more than 18% since the company’s earnings call on May 11, which has helped drag its one-year performance down to a loss of more than 50%. Hims & Hers Health, Inc. (HIMS) Price Chart for Thursday, May, 28, 2026 But amid the fallout was a somewhat overlooked reminder that the San Francisco-based company is not just eyeing international expansion, it is actively pursuing it with a controversial financing plan. Hims & Hers’ Path to Global Expansion Begins With EucalyptusHims & Hers Health TodayHIMSHims & Hers Health$25.34 +0.14 (+0.56%) As of 10:12 AM Eastern This is a fair market value price provided by Massive. Learn more.52-Week Range$13.74▼$70.43Price Target$28.70 Hims & Hers isn’t aiming to compete with Big Pharma giants like Eli Lilly NYSE: LLY and AbbVie NYSE: ABBV. Instead, the company is embracing its niche role as a healthcare disruptor that is capitalizing on the GLP-1 weight loss, hair loss, sexual health, mental health, and dermatology markets by offering telehealth access in the United States and—possibly abroad in the second half of 2026. That begins with Hims & Hers' planned acquisition of Australian telehealth platform Eucalyptus, which was announced on Feb. 19. The $1.15 billion deal is expected to close in the second half of this year, and would mark the company's latest foray into the globa...